Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

641 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
American Heart Association Cardiogenic Shock Registry: Design and Implementation.
Morrow DA, Jessup M, Abraham WT, Acker M, Aringo A, Batchelor W, Chikwe J, Costello S, Drakos SG, Farmer S, Gelijns A, Gillette N, Hochman JS, Isler M, Kapur NK, Kilic A, Kormos R, Lewis EF, Lindenfeld J, Lombardi P, Mancini D, Rao SV, Rutan C, Samsky M, Krucoff MW. Morrow DA, et al. Among authors: mancini d. Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010637. doi: 10.1161/CIRCOUTCOMES.123.010637. Epub 2024 Jun 18. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38887950
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ; Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators. Jessup M, et al. Among authors: mancini d. Circulation. 2011 Jul 19;124(3):304-13. doi: 10.1161/CIRCULATIONAHA.111.022889. Epub 2011 Jun 27. Circulation. 2011. PMID: 21709064 Free PMC article. Clinical Trial.
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M. Hajjar RJ, et al. Among authors: mancini d. J Card Fail. 2008 Jun;14(5):355-67. doi: 10.1016/j.cardfail.2008.02.005. Epub 2008 May 27. J Card Fail. 2008. PMID: 18514926 Clinical Trial.
Report from a consensus conference on antibody-mediated rejection in heart transplantation.
Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A; Consensus Conference Participants. Kobashigawa J, et al. Among authors: mancini d. J Heart Lung Transplant. 2011 Mar;30(3):252-69. doi: 10.1016/j.healun.2010.11.003. J Heart Lung Transplant. 2011. PMID: 21300295 Free PMC article.
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes.
Genuardi MV, Moss N, Najjar SS, Houston BA, Shore S, Vorovich E, Atluri P, Molina M, Chambers S, Sharkoski T, Hsich E, Estep JD, Owens AT, Alexander KM, Chaudhry SP, Garcia-Cortes R, Molina E, Rodrigo M, Wald MJ, Margulies KB, Hanff TC, Zimmer R, Kilic A, Mclean R, Vidula H, Dodd K, Blumberg EA, Mazurek JA, Goldberg LR, Alvarez-Garcia J, Mancini D, Teuteberg JJ, Tedford RJ, Birati EY. Genuardi MV, et al. Among authors: mancini d. J Heart Lung Transplant. 2021 Sep;40(9):926-935. doi: 10.1016/j.healun.2021.05.006. Epub 2021 May 19. J Heart Lung Transplant. 2021. PMID: 34140222 Free PMC article.
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P. Mehra MR, et al. Among authors: mancini d. Am Heart J. 2007 Jun;153(6):932-40. doi: 10.1016/j.ahj.2007.03.038. Am Heart J. 2007. PMID: 17540193 Clinical Trial.
Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F; Consensus Conference participants. Kobashigawa J, et al. Among authors: mancini d. J Heart Lung Transplant. 2014 Apr;33(4):327-40. doi: 10.1016/j.healun.2014.02.027. Epub 2014 Mar 5. J Heart Lung Transplant. 2014. PMID: 24661451
The New Adult Heart Allocation Policy: A Work in Progress.
Colvin MM, Mancini DM. Colvin MM, et al. Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e007000. doi: 10.1161/CIRCOUTCOMES.120.007000. Epub 2020 Sep 29. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32988231 No abstract available.
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes.
Shahzad K, Aziz QA, Leva JP, Cadeiras M, Ho EK, Vlad G, Vasilescu ER, Latif F, Sinha A, Burke E, Addonizio LJ, Restaino SW, Marboe CC, Suciu-Foca N, Naka Y, Mancini D, Deng MC. Shahzad K, et al. Among authors: mancini d. J Heart Lung Transplant. 2011 Feb;30(2):194-203. doi: 10.1016/j.healun.2010.08.026. Epub 2010 Oct 16. J Heart Lung Transplant. 2011. PMID: 20952209
641 results